GENDER SPECIFIC DIFFERENCES IN ANKYLOSING SPONDYLITIS AT TREATMENT INITIATION IN PATIENTS TREATED WITH INFLIXIMAB OR GOLIMUMAB

被引：0
|
作者：
Starr, M. [1 ]
Zummer, M. [2 ]
Choquette, D. [3 ]
Haraoui, B. [3 ]
Rahman, P. [4 ]
Sheriff, M. [5 ]
Rampakakis, E. [6 ]
Psaradellis, E. [6 ]
Osborne, B. [7 ]
Lehman, A. J. [7 ]
Maslova, K. [7 ]
Nantel, F. [7 ]
Tkaczyk, C. M. [7 ]
机构：
[1] McGill Univ, Montreal, PQ, Canada
[2] Hop Maison Neuve Rosemont, Montreal, PQ, Canada
[3] Inst Rhumatol Montreal, Montreal, PQ, Canada
[4] Mem Univ, St John, NF, Canada
[5] Nanaimo Reg Hosp, Nanaimo, BC, Canada
[6] JSS Med Res, Montreal, PQ, Canada
[7] Janssen, Toronto, ON, Canada
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.4740
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0684
引用
下载
收藏
页码：1138 / 1139
页数：2
相关论文
共 50 条
  • [21] Are Patients with Ankylosing Spondylitis Willing to Pay for Treatment with Infliximab?
    Webers, Casper
    Essers, Ivette
    van Tubergen, Astrid
    Braun, Juergen
    Heldmann, Frank
    Baraliakos, Xenofon
    Boonen, Annelies
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [22] ARE THERE GENDER SPECIFIC DIFFERENCES IN PATIENT REPORTED OUTCOMES AT INITIATION OF GOLIMUMAB TREATMENT IN RHEUMATOID ARTHRITIS?
    Sholter, D.
    Bensen, W. G.
    Choquette, D.
    Fortin, I.
    Arendse, R.
    Kelsall, J.
    Sheriff, M.
    Faraawi, R.
    Rodrigues, J.
    Zummer, M.
    Dixit, S.
    Starr, M.
    Rampakakis, E.
    Sampalis, J. S.
    Nantel, F.
    Shawi, M.
    Otawa, S.
    Lehman, A. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1145 - 1145
  • [23] Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumab
    Wagner, Carrie
    Visvanathan, Sudha
    Braun, Juergen
    van der Heijde, Desiree
    Deodhar, Atul
    Hsu, Benjamin
    Mack, Michael
    Elashoff, Michael
    Inman, Robert D.
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (05) : 674 - 680
  • [24] PREVALENCE OF SMOKING AND IMPACT ON DISEASE PARAMETERS AMONG ANKYLOSING SPONDYLITIS, RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB OR GOLIMUMAB
    Faraawi, R.
    Dixit, S.
    Mulgund, M.
    Bensen, W.
    Kelsall, J.
    Choquette, D.
    Baker, M.
    Fortin, I.
    Sampalis, J.
    Rampakakis, E.
    Tkaczyk, C.
    Lehman, A.
    Nantel, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1291 - 1292
  • [25] Maintenance of infliximab treatment in ankylosing spondylitis
    Breban, Maxime
    Ravaud, Philippe
    Claudepierre, Pascal
    Baron, Gabriel
    Henry, Yves-Dorninique
    Hudry, Christophe
    Euller-Ziegler, Liana
    Pham, Thao
    Solau-Gervais, Elisabeth
    Chary-Valckenaere, Isabelle
    Marcelli, Christian
    Perdriger, Aleth
    Le Loet, Xavier
    Wendling, Daniel
    Fautrel, Bruno
    Fournie, Bernard
    Combe, Bernard
    Gaudin, Philippe
    Jousse, Sandrine
    Mariette, Xavier
    Baleydier, Alain
    Trape, Gerard
    Dougados, Maxime
    ARTHRITIS AND RHEUMATISM, 2008, 58 (01): : 88 - 97
  • [26] Impact of Gender and Age on Ankylosing Spondylitis Patient Profiles at Golimumab Initiation and 12-Month Outcomes
    Masetto, Ariel
    Rahman, Proton
    Teo, Michelle
    Boulos, Pauline
    Rampakakis, Emmanouil
    Rachich, Meagan
    Lehman, Allen
    Nantel, Francois
    Asin-Milan, Odalis
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 759 - 760
  • [27] Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab
    Lorenzin, Mariagrazia
    Ortolan, Augusta
    Frallonardo, Paola
    Oliviero, Francesca
    Punzi, Leonardo
    Ramonda, Roberta
    BMC MUSCULOSKELETAL DISORDERS, 2015, 16
  • [28] Augmentation index in patients with rheumatoid arthritis and ankylosing spondylitis treated with infliximab
    Herwig Pieringer
    Ulrike Stuby
    Erich Pohanka
    Georg Biesenbach
    Clinical Rheumatology, 2010, 29 : 723 - 727
  • [29] Augmentation index in patients with rheumatoid arthritis and ankylosing spondylitis treated with infliximab
    Pieringer, Herwig
    Stuby, Ulrike
    Pohanka, Erich
    Biesenbach, Georg
    CLINICAL RHEUMATOLOGY, 2010, 29 (07) : 723 - 727
  • [30] Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab
    Mariagrazia Lorenzin
    Augusta Ortolan
    Paola Frallonardo
    Francesca Oliviero
    Leonardo Punzi
    Roberta Ramonda
    BMC Musculoskeletal Disorders, 16
12345